Cargando…
Richter's transformation as leptomeningeal infiltration in a chronic lymphocytic leukemia patient receiving venetoclax. Could blood‐brain barrier be a disease “sanctuary” during venetoclax treatment?
Our unique case of Richter's Transformation presenting as leptomeningial infiltration in a CLL patient receiving venetoclax raises questions on whether the drug penetrates the blood‐brain barrier and at what extend, especially in reduced doses given for drug‐drug interactions.
Autores principales: | Dimou, Maria, Bitsani, Aikaterini, Roumelioti, Maria, Dimitrakopoulou, Aglaia, Iliakis, Theodore, Pardalis, Vasileios, Grafakos, Ioannis, Kalyva, Sotiria, Markopoulos, Athanasios, Kyrtsonis, Marie‐Christine, Panayiotidis, Panayiotis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077271/ https://www.ncbi.nlm.nih.gov/pubmed/33936674 http://dx.doi.org/10.1002/ccr3.4002 |
Ejemplares similares
-
Complete eradication of chronic lymphocytic leukemia with unusual skin involvement of high mitotic index after time‐limited venetoclax/obinutuzumab treatment
por: Dimou, Maria, et al.
Publicado: (2021) -
Durable Response to Venetoclax Monotherapy in Richter’s Syndrome: A Case Report and Review of Literature
por: Kollipara, Revathi, et al.
Publicado: (2019) -
Long-term effect of venetoclax therapy in a patient with the transformation of chronic lymphocytic leukemia into Richter’s syndrome
por: Tutaeva, Victoria Vladimirovna, et al.
Publicado: (2022) -
Correction to: Long-term effect of venetoclax therapy in a patient with the transformation of chronic lymphocytic leukemia into Richter’s syndrome
Publicado: (2023) -
Tumor Lysis Syndrome Caused by Unrecognized Richter’s Transformation of Chronic Lymphocytic Leukemia: Treatment With Venetoclax for Suspected Disease Progression
por: Chango Azanza, Juan Jose, et al.
Publicado: (2020)